ALLOGENEIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising blood cancer trial pulled before it began
Disease control TerminatedThis study was designed to see if the drug ASTX727, alone or with donor immune cells, could help control blood cancers that return after a stem cell transplant. It was planned for adults aged 18 to 75 with certain high-risk blood cancers. However, the trial was withdrawn before e…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:14 UTC
-
New hope for older leukemia patients: drug may keep cancer away after transplant
Disease control OngoingThis study tests whether the drug ruxolitinib can help prevent acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) from coming back after a stem cell transplant. It includes older adults whose cancer is in remission. The goal is to improve survival and reduce complicat…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 22, 2026 14:01 UTC